Higher-order SPOP assembly reveals a basis for cancer mutant dysregulation
- PMID: 36693379
- PMCID: PMC9992347
- DOI: 10.1016/j.molcel.2022.12.033
Higher-order SPOP assembly reveals a basis for cancer mutant dysregulation
Abstract
The speckle-type POZ protein (SPOP) functions in the Cullin3-RING ubiquitin ligase (CRL3) as a receptor for the recognition of substrates involved in cell growth, survival, and signaling. SPOP mutations have been attributed to the development of many types of cancers, including prostate and endometrial cancers. Prostate cancer mutations localize in the substrate-binding site of the substrate recognition (MATH) domain and reduce or prevent binding. However, most endometrial cancer mutations are dispersed in seemingly inconspicuous solvent-exposed regions of SPOP, offering no clear basis for their cancer-causing and peculiar gain-of-function properties. Herein, we present the first structure of SPOP in its oligomeric form, uncovering several new interfaces important for SPOP self-assembly and normal function. Given that many previously unaccounted-for cancer mutations are localized in these newly identified interfaces, we uncover molecular mechanisms underlying dysregulation of SPOP function, with effects ranging from gross structural changes to enhanced self-association, and heightened stability and activity.
Keywords: cryo-EM; endometrial cancer; filament; gain of function; higher-order oligomer; hypermorphic; oncogene; prostate cancer; structure; tumor suppressor.
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests T.M. was a consultant for Faze Medicines, Inc. and is a member of the journal’s advisory board.
Figures







Comment in
-
Hidden tricks in MATH: Hypermorphic mutations in SPOP tumor suppressor explained by cryo-EM.Mol Cell. 2023 Mar 2;83(5):655-656. doi: 10.1016/j.molcel.2023.02.003. Mol Cell. 2023. PMID: 36868187 Free PMC article.
References
-
- Geng C, He B, Xu L, Barbieri CE, Eedunuri VK, Chew SA, Zimmermann M, Bond R, Shou J, Li C, et al. (2013). Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover. Proc Natl Acad Sci U S A 110, 6997–7002. 10.1073/pnas.1304502110. - DOI - PMC - PubMed
-
- Janouskova H, El Tekle G, Bellini E, Udeshi ND, Rinaldi A, Ulbricht A, Bernasocchi T, Civenni G, Losa M, Svinkina T, et al. (2017). Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors. Nat Med 23, 1046–1054. 10.1038/nm.4372. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials